About TYSABRI MS Treatment

What is TYSABRI?

TYSABRI is a prescription medicine approved for patients with relapsing forms of multiple sclerosis (MS). TYSABRI works to:

  • Slow the worsening of disability that is common in patients with MS
  • Decrease the number of flare-ups (relapses)

What makes TYSABRI different?

1) It works in a different way.

  • TYSABRI is an antibody, not an interferon or Copaxone®. An antibody is a protein made by your immune system
  • TYSABRI is thought to inhibit white blood cells from getting into the brain and attacking nerves
  • Keeping these cells from attacking nerves is believed to result in fewer brain lesions that cause multiple sclerosis symptoms
  • The way in which TYSABRI works has been studied, but the exact way that TYSABRI works is not fully known
TYSABRI calendar

2) It is taken differently than other multiple sclerosis medicines.

  • With TYSABRI, you can avoid the hassles of self-injection
  • TYSABRI is infused into a vein once every 4 weeks

 

TYSABRI may offer many MS patients the strength to reach their high hopes. It has been proven to slow the worsening of disability and lower the frequency of flare-ups. TYSABRI has also been shown to reduce the number of new-active MRI lesions.*

Like all medicines, TYSABRI should only be used by certain patients. Find out who should and should not receive TYSABRI.

Like all medicines, treatment with TYSABRI has benefits and risks. You need to know as much as possible about both before you start TYSABRI.

Like all medicines, treatment with TYSABRI may come with side effects. Learn more about them here.

TYSABRI is different. Learn more about the different way TYSABRI works.

 

Copaxone® (glatiramer acetate injection) is a registered trademark of Teva Pharmaceutical Industries Ltd.

*It is not known exactly how well MRI findings relate to how your MS is progressing.

 


  previous  |   next    The Effectiveness of TYSABRI
Important Safety Information

 

Please see full Prescribing Information, including Boxed Warning and Patient Medication Guide.

© 2008 Biogen Idec. This site is intended for residents of the United States, Puerto Rico, and US territories only.

TYSABRI® is a registered trademark and TOUCH™ is a trademark of Elan Pharmaceuticals, Inc.

BIOGEN IDEC™ is a trademark of BIOGEN IDEC.